Tradestie Institutional Equity Comparison Engine
GDT vs BSX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BSX Overall Edge
BSX Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Boston Scientific Corp. (BSX) driven by superior Valuation, Growth & Margin, Options & Structure while GDT counters with relative strength in Momentum & Technical. Fundamentally, GDT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BSX at 14.0x Forward P/E and 19.6% operating margin (+1.4% YoY). In options structure, GDT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BSX sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BSX
GDT N/M vs BSX 14.0x Fwd P/E
Growth & Margin Winner
BSX
Op Margin N/A vs 19.6% ยท YoY N/A vs +1.4%
Momentum & Technical Winner
GDT
1Y -24.2% vs -58.4% ยท 52W Pos 0% vs 6%
Options & Structure Winner
BSX
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (31st %ile IV)
GDT
US Equity
GDT
Institutional Equity
$31.31
-0.57% 1D
Market Cap
N/A
1M Return
-7.89%
1Y Return
-24.23%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 37.0
Fund 55.0
Flow 50.0
Mom 60.0
BSX
NYSE
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
$43.69
-1.47% 1D
Market Cap
$64.3B
1M Return
-1.58%
1Y Return
-58.38%
Forward P/E
14.0x
Unified AI Score
52.9 / 100
HOLD
Tech 49.0
Fund 58.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
GDT -24.23%
BSX -58.38%
Spread: +27.91 pp (GDT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
GDT TTM Op. Margin: N/A
BSX TTM Op. Margin: 19.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GDT vs BSX. Trailing 12-month operating profitability (GDT N/A vs BSX 19.6%) and valuation multiples (GDT N/M vs BSX 14.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GDT | BSX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $64.3B | Larger Scale | BSX |
| Trailing P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | BSX |
| Forward P/E Ratio Valuation | N/M | 14.0x | Lower Multiple | BSX |
| Revenue Growth (YoY) Growth | N/A | +1.4% | Higher Growth | BSX |
| Operating Margin (TTM) Profitability | N/A | 19.6% | Higher Margin | BSX |
| Net Profit Margin Profitability | N/A | 16.6% | Higher Margin | BSX |
| Return on Equity (ROE) Capital Efficiency | N/A | 14.1% | Higher ROE | BSX |
| 52-Week Range Position Momentum | 0% ($31โ$46) | 6% ($40โ$106) | Stronger Trend | BSX |
| Beta / 30D Volatility Risk Regime | 0.76ฮฒ ยท 24% Vol | 0.32ฮฒ ยท 45% Vol | Lower Realized Risk | GDT |
| Unified Institutional Score Composite Signal | 45.5 / 100 (HOLD) | 52.9 / 100 (HOLD) | Higher Composite | BSX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full GDT vs BSX Buy Guide
GDT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BSX
CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
31st %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither GDT nor BSX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.